Trials / Withdrawn
WithdrawnNCT00899808
Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
Molecular and Genetic Markers in the Local-regional Management of Patients Undergoing Radiation Therapy
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research study is looking at molecular markers and genetic markers in patients undergoing radiation therapy for cancer.
Detailed description
OBJECTIVES: Primary * Determine local-regional control in patients undergoing radiation therapy for cancer, as a function of expression of specific molecular/genetic markers. Secondary * Determine complications of radiation therapy for patients undergoing radiation therapy for cancer. OUTLINE: Previously collected tissue samples are analyzed using immunohistochemical staining and other molecular/genetic study methods to detect markers, including p53, cyclin D1, HER-2-neu, bcl-2/BAX, and EGFR. Patient charts are also reviewed with emphasis on local-regional relapse.
Conditions
- Hematopoietic/Lymphoid Cancer
- Unspecified Adult Solid Tumor, Protocol Specific
- Unspecified Childhood Solid Tumor, Protocol Specific
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2006-05-01
- First posted
- 2009-05-12
- Last updated
- 2015-05-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00899808. Inclusion in this directory is not an endorsement.